Interleukin 28 is a potential therapeutic target for sepsis.

This study defines IL-28 as a detrimental mediator during sepsis and identifies a potential therapeutic target for the immune therapy in sepsis.
PMID: 31121287 [PubMed - as supplied by publisher]

Source: Clinical Immunology - May 19, 2019 Category: Allergy & Immunology Authors: Luo Q, Liu Y, Liu S, Yin Y, Xu B, Cao J Tags: Clin Immunol Source Type: research